Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Celgene Names Julia A. Haller To Board

This article was originally published in Scrip

Executive Summary

Celgene Corp. has appointed Julia A. Haller to its board of directors. Haller is ophthalmologist-in-chief of the Wills Eye Hospital and holds the William Tasman, M.D. endowed chair. She is also professor and chair of the department of ophthalmology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals and is co-director of the Wills Vision Research Center at Jefferson. Previously Haller was the first female chief resident at the Wilmer Eye Institute at Johns Hopkins and later joined its faculty. She was named the inaugural Katharine Graham professor ophthalmology in 2002 and the inaugural Robert Bond Welch, M.D. professor of ophthalmology in 2006.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts